major insurance changes are coming to glp 1 📢 Two important dates for patients interested in GLP-1 medications: ✓ July 1, 2026 – Medicare GLP-1 Bridge Program begins for eligible Medicare Part D beneficiaries. ✓ October 1, 2026 – Zepbound Nutritional priorities to support GLP-1

Deletion of GIP receptor has been found to counteract high-fat diet induced weight gain in mice, suggesting a causal role of GIP in development of obesity [36]

Ramachandra and other doctors are keeping their eye on the ratio of fat loss and muscle loss in patients taking GLP-1s compared to those who have bariatric surgery

Were proving that its possible to offer access to GLP-1s affordably and with dignity and that doing so can benefit both people and the bottom line. The personal impact of these medications extends beyond just the numbers

However, if you are more sensitive to side effects, semaglutide could be a better starting point

INCA: a computational platform for isotopically non-stationary metabolic flux analysis

In adults with obesity who achieved weight loss on a low-calorie diet, adding liraglutide, a GLP-1 receptor agonist, plus regular moderate-to-vigorous exercise for one year further lowered metabolic syndrome severity and abdominal fat